These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11545668)

  • 1. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.
    Chen P; Ratcliff G; Belle SH; Cauley JA; DeKosky ST; Ganguli M
    Arch Gen Psychiatry; 2001 Sep; 58(9):853-8. PubMed ID: 11545668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.
    Chen P; Ratcliff G; Belle SH; Cauley JA; DeKosky ST; Ganguli M
    Neurology; 2000 Dec; 55(12):1847-53. PubMed ID: 11134384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education and rates of cognitive decline in incident Alzheimer's disease.
    Scarmeas N; Albert SM; Manly JJ; Stern Y
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):308-16. PubMed ID: 16484637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A; Adam S; Van der Linden M; Salmon E; Juillerat AC; Mulligan R; Seron X
    J Neurol; 2005 Jan; 252(1):47-55. PubMed ID: 15654553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment.
    Pereira FS; Yassuda MS; Oliveira AM; Forlenza OV
    Int Psychogeriatr; 2008 Dec; 20(6):1104-15. PubMed ID: 18752698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.
    Maurano STP; da Silva DJ; Ávila MP; Magacho L
    Int Ophthalmol; 2018 Oct; 38(5):1839-1844. PubMed ID: 28744790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal cognitive decline in patients with Alzheimer's disease.
    Rebok G; Brandt J; Folstein M
    J Geriatr Psychiatry Neurol; 1990; 3(2):91-7. PubMed ID: 2206264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset.
    Saxton J; Lopez OL; Ratcliff G; Dulberg C; Fried LP; Carlson MC; Newman AB; Kuller L
    Neurology; 2004 Dec; 63(12):2341-7. PubMed ID: 15623697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.
    Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does executive impairment define a frontal variant of Alzheimer's disease?
    Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R;
    Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating illiteracy from Alzheimer's disease by using neuropsychological assessments.
    Youn JH; Siksou M; Mackin RS; Choi JS; Chey J; Lee JY
    Int Psychogeriatr; 2011 Dec; 23(10):1560-8. PubMed ID: 21777502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls.
    Pavlik V; Massman P; Barber R; Doody R
    J Alzheimers Dis; 2013; 34(2):449-56. PubMed ID: 23241558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.
    Small BJ; Fratiglioni L; Viitanen M; Winblad B; Bäckman L
    Arch Neurol; 2000 Jun; 57(6):839-44. PubMed ID: 10867781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
    Langbaum JB; Hendrix SB; Ayutyanont N; Chen K; Fleisher AS; Shah RC; Barnes LL; Bennett DA; Tariot PN; Reiman EM
    Alzheimers Dement; 2014 Nov; 10(6):666-74. PubMed ID: 24751827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.